Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    Open Studies | "Poxviridae Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Poxviridae Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
2 Recruiting A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Intervention: Biological: GL-ONC1
3 Not yet recruiting A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: Prevention in 18-40 Year Old Healthy Vaccinia-naïve Subjects
Interventions: Biological: MVA BN®;   Biological: ACAM2000
4 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
5 Not yet recruiting A Dose Range-Finding Phase 2 Trial of a Botanical Drug for the Treatment of Molluscum Contagiosum in Pediatric Subjects
Condition: Molluscum Contagiosum
Interventions: Drug: 2.5% East Indian sandalwood oil cream;   Drug: 5% East Indian sandalwood oil cream;   Drug: 10% East Indian sandalwood oil cream;   Drug: Placebo Cream
6 Unknown  Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium;   Drug: Placebo
7 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
8 Recruiting Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Condition: Smallpox
Intervention:
9 Recruiting Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
10 Recruiting Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
Condition: Cancer of Head and Neck
Intervention: Biological: GL-ONC1

Indicates status has not been verified in more than two years